Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin
Clinical trial NCT05694221 · COMPLETED
Trial details
- NCT number
- NCT05694221
- Sponsor
- Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2023-06-06
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.